Scholar Rock Holding Corporation Common Stock
Symbol: SRRK (NASDAQ)
28.25
▼ (-0.95%) -0.270
Company Description:
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
Key Stats
- Today's Open: $28.83
- Today's High: $29
- Today's Low: $28.206
- Today's Volume: 94.41K
- Yesterday Close: $28.52
- Yesterday High: $29.35
- Yesterday Low: $27.96
- Yesterday Volume: 3.04M
- Last Min Volume: 1.02K
- Last Min High: $28.295
- Last Min Low: $28.206
- Last Min VWAP: $28.26171
Company Profile
- Name: Scholar Rock Holding Corporation Common Stock
- Website: https://www.scholarrock.com
- Listed Date: 2018-05-24
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001727196
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $2.71B
- Round Lot: 100
- Outstanding Shares: 96.13M
- Asset Type: CS
RECENT FILINGS FOR SRRK
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-14 | 8-K | View |
| 2025-10-09 | 4 | View |
| 2025-10-07 | SCHEDULE 13D/A | View |
| 2025-10-07 | 4 | View |
| 2025-09-24 | 4 | View |
| 2025-09-23 | 8-K | View |
| 2025-09-22 | 144 | View |
| 2025-09-17 | 4 | View |
| 2025-09-17 | 4 | View |
| 2025-09-16 | 144 | View |
| 2025-08-19 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-07-18 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-08 | 144 | View |
| 2025-06-25 | 4 | View |
| 2025-06-18 | 8-K | View |
| 2025-06-17 | 4 | View |
Latest News on SRRK